Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Up - Time to Buy?

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc.'s stock price increased from a previous close of $4.65 to open at $4.85 on Tuesday, with recent trading volume recorded at 461 shares.
  • The company received a "hold" rating from Wall Street Zen, contributing to a consensus rating of "Hold" with an average price target set at $13.00.
  • Veradigm is a healthcare technology company specializing in solutions such as electronic health records (EHR), analytics, and population health management for healthcare organizations across several regions.
  • Need better tools to track Veradigm? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $4.65, but opened at $4.85. Veradigm shares last traded at $4.85, with a volume of 461 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen started coverage on Veradigm in a report on Tuesday, May 20th. They issued a "hold" rating for the company. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $13.00.

Check Out Our Latest Stock Analysis on Veradigm

Veradigm Price Performance

The company has a 50-day simple moving average of $4.65 and a 200 day simple moving average of $4.61.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines